-
Genentech asking FDA for accelerated approval for drug to treat early-stage HER-2 breast cancer
Madely Health Headlines Commentary for September 11, 2013 [display_podcast] Source: FDA backs accelerated approval for drug to treat early-stage breast cancer CORRECTION: In the interview I state that the drug is not approved for use. It is indeed approved for the treatment of late-stage aggressive HER-2 breast cancer.
-
Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study
Madely Health Headlines Commentary for October 3, 2012 [display_podcast] Source: Breast cancer treatment targets tumours with few side effects Reference: Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
-
Combination therapy for invasive non-metastatic HER-2 breast cancer shows promise
Madely Health Headlines Commentary for December 13, 2010 [display_podcast] Source: Breast cancer drug combo shows promise: study